Genprex retains pharma branding agency to select a name for its lead drug

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner tells Proactive Investors the biotech has moved one step closer to commercializing its flagship drug candidate Oncoprex by retaining pharmaceutical branding agency Addison Whitney. Varner says Addison Whiteney is helping with the naming process of the drug, which could take a few...

 
STAY IN THE KNOW WITH
EMAIL NEWS ALERTS
 
Don't miss out. Get our news delivered to your inbox.
 

 
close-link
 
Get Email News Alerts
 
close-link